Akari Therapeutics Plc (AKTX)
4.86
+0.25
(+5.42%)
USD |
NASDAQ |
Apr 16, 16:00
4.86
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Free Cash Flow : -10.59M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -122.10M |
| Cellectis SA | -43.68M |
| Biodexa Pharmaceuticals Plc | -8.310M |
| Mereo BioPharma Group Plc | -31.36M |
| Bicycle Therapeutics Plc | -252.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.039M |
| Cash from Financing (Quarterly) | 5.764M |
| Free Cash Flow to Equity (Quarterly) | -1.676M |
| Free Cash Flow to Firm (Quarterly) | -2.305M |
| Free Cash Flow Yield | -22.63% |